BackgroundPulmonary hypertension (PH), right ventricular (RV) dysfunction, and tricuspid regurgitation (TR) are commonly present in patients with mitral regurgitation (MR) and known to impair prognosis. This systematic review and meta-analysis aimed to determine the prognostic value of PH, RV function, and TR on mortality after transcatheter mitral valve repair (TMVR).
MethodsA systematic search was performed to identify studies investigating PH, RV function, or TR in patients who underwent TMVR. Studies were included for pooled analysis if hazard ratios (HR) for all-cause mortality were given.
ResultsA total of 8,672 patients from 21 selected studies were included (PH, 11 studies; RV function, nine studies; TR, 10 studies). Mean follow-up was 2.761.6 years. The HRs and 95% CIs for all-cause mortality of PH (dichotomised: HR 1.70 95% CI 1.00-2.87; per 10 mmHg increase in systolic PAP: HR 1.17 95% CI 1.07-1.29), RV function (dichotomised: HR 1.86 95% CI 1.45-2.38; per 5 mm decrease in TAPSE: HR 1.18 95% CI 0.97-1.43) and TR (HR 1.51 95% CI 1.28-1.79) indicated a significant association.
ConclusionPrognosis after TMVR is worse in patients with significant MR when concomitant PH, RV dysfunction, or TR are present. Careful assessment of these parameters should therefore precede clinical decision-making for TMVR. The current results encourage investigation into whether (1) intervention at an earlier stage of MR reduces incidence of PH, RV dysfunction, and TR; and (2) transcatheter treatment of concomitant TR can improve clinical outcome and prognosis for these patients.